Catalent
CTLT
#1756
Rank
NZ$19.84 B
Marketcap
NZ$109.31
Share price
0.00%
Change (1 day)
13.07%
Change (1 year)
Catalent is an American pharmaceutical contract research and development company.

EPS for Catalent (CTLT)

EPS in 2024 (TTM): NZ-$10.40

According to Catalent's latest financial reports the company's current EPS (TTM) is NZ-$10.90. In 2023 the company made an earnings per share (EPS) of NZ-$11.71 a decrease over its 2022 EPS that were of NZ$3.91.

EPS history for Catalent from 2014 to 2024

Annual EPS

Year EPS Change
2024 (TTM)NZ-$10.40-11.21%
2023NZ-$11.71-399.56%
2022NZ$3.91-30.58%
2021NZ$5.6379.67%
2020NZ$3.13114.12%
2019NZ$1.46-15%
2018NZ$1.7275.44%
2017NZ$0.98-22.97%
2016NZ$1.27-59.56%
2015NZ$3.15282.05%
2014NZ$0.82

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Supernus Pharmaceuticals
SUPN
NZ-$0.57-94.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
NZ-$1.29-88.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Jazz Pharmaceuticals
JAZZ
NZ-$10.26-5.85%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Intercept Pharmaceuticals
ICPT
NZ-$2.55-76.62%๐Ÿ‡บ๐Ÿ‡ธ USA